financetom
Business
financetom
/
Business
/
HC quashes CRZ clearances to Rs 14,000 crore coastal road project: Experts discuss
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
HC quashes CRZ clearances to Rs 14,000 crore coastal road project: Experts discuss
Jul 16, 2019 11:49 AM

The Bombay High Court on Tuesday quashed the CRZ clearances granted to the city civic body's ambitious Rs 14,000-crore coastal road project, saying there was "serious lacuna" in the decision-making process and lack of proper scientific study.

A division bench of Chief Justice Pradeep Nandrajog and Justice N M Jamdar in its ruling said the Brihanmumbai Municipal Corporation (BMC) cannot proceed with work on the 29.2 km-long project, proposed to connect Marine Drive area in south Mumbai to suburban Borivali in north Mumbai.

The court noted that the environmental clearance was required to be taken by the BMC under Environmental Impact Assessment (EIA) notification issued by the centre.

"We declare that the civic body cannot proceed with the works without obtaining an environmental clearance under EIA notification. Further, permission under the Wildlife (Protection) Act-1972 should also be obtained," the high court said.

The bench quashed the Coastal Regulation Zone (CRZ) clearances while allowing a bunch of petitions filed by activists, residents and fishermen from the city challenging the project.

CNBC-TV18's Manisha Natarajan is in conversation with the petitioner Shweta Wagh and Hafeez Contractor, architect, who believes it’s a disservice to the city to not have the coastal road.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Summit Therapeutics' Closely-Watched Lung Cancer Study Of Ivonescimab Misses Overall Survival Endpoint
Summit Therapeutics' Closely-Watched Lung Cancer Study Of Ivonescimab Misses Overall Survival Endpoint
May 30, 2025
Summit Therapeutics Inc. ( SMMT ) released topline results on Friday from the Phase 3 HARMONi trial of ivonescimab plus platinum-doublet chemotherapy compared to placebo plus platinum-doublet chemotherapy for epidermal growth factor receptor (EGFR)-mutated, locally advanced or metastatic non-squamous non-small cell lung cancer (NSCLC) who have progressed after treatment with a 3rd generation EGFR tyrosine kinase inhibitor (TKI). The trial met the...
Vivakor to Issue Special Dividend in Adapti Shares
Vivakor to Issue Special Dividend in Adapti Shares
May 30, 2025
09:05 AM EDT, 05/30/2025 (MT Newswires) -- Vivakor ( VIVK ) said Friday it plans to issue a special dividend of 0.0079 shares of Adapti per Vivakor ( VIVK ) share. Vivakor ( VIVK ), which currently holds at 13.5% stake in Adapti, said it will establish a record date for the dividend in the next couple of weeks. The...
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Herc Completes Tender Offer for H&E, Deal Close Set for June 2
Herc Completes Tender Offer for H&E, Deal Close Set for June 2
May 30, 2025
09:01 AM EDT, 05/30/2025 (MT Newswires) -- Herc Holdings ( HRI ) said Friday its tender offer to acquire H&E Equipment Services ( HEES ) expired at one minute past 11:59 pm ET on Thursday. The company said that roughly 69% of H&E shares were tendered by the deadline and will be paid in cash and stock as previously outlined....
Copyright 2023-2026 - www.financetom.com All Rights Reserved